Cite
The MaDo real-life study of dose adjustment of allergen immunotherapy liquid formulations in an indication of respiratory allergic disease: Reasons, practices, and outcomes
MLA
Marguerite Thétis-Soulié, et al. “The MaDo Real-Life Study of Dose Adjustment of Allergen Immunotherapy Liquid Formulations in an Indication of Respiratory Allergic Disease: Reasons, Practices, and Outcomes.” Frontiers in Allergy, vol. 3, Aug. 2022. EBSCOhost, https://doi.org/10.3389/falgy.2022.971155.
APA
Marguerite Thétis-Soulié, Maxime Hosotte, Isabelle Grozelier, Claire Baillez, Silvia Scurati, & Valérie Mercier. (2022). The MaDo real-life study of dose adjustment of allergen immunotherapy liquid formulations in an indication of respiratory allergic disease: Reasons, practices, and outcomes. Frontiers in Allergy, 3. https://doi.org/10.3389/falgy.2022.971155
Chicago
Marguerite Thétis-Soulié, Maxime Hosotte, Isabelle Grozelier, Claire Baillez, Silvia Scurati, and Valérie Mercier. 2022. “The MaDo Real-Life Study of Dose Adjustment of Allergen Immunotherapy Liquid Formulations in an Indication of Respiratory Allergic Disease: Reasons, Practices, and Outcomes.” Frontiers in Allergy 3 (August). doi:10.3389/falgy.2022.971155.